Description
CJC-1295 DAC: Enhancing Growth Hormone Secretion
CJC-1295 DAC, a member of the tetra-substituted peptide hormone family, is a game-changer in the realm of growth hormone modulation. Comprising 30 amino acids, this modified version of GRF 1-29 exhibits a remarkable affinity for GHRH receptors, paving the way for enhanced growth hormone release.
Originally crafted by Canadian researchers, CJC-1295 DAC aims to extend the half-life of growth hormone-releasing hormone (GHRH). Studies have shown that this synthetic complex stimulates GHRH and IGF-1 secretion while keeping prolactin levels in check. Moreover, CJC-1295 DAC promotes lipolysis and protein biosynthesis, offering a dual benefit for body composition enhancement.
The strategic arrangement of biomolecular components in CJC-1295 DAC ensures prolonged stability and enhanced efficacy. Renowned for its ability to target visceral fat, this compound has garnered attention since the early 2000s. With a relative half-life ranging from 5.8 to 8.1 days, the addition of IGF-1 further extends its longevity, potentially up to 30 days.
Ongoing research endeavors aim to uncover additional benefits of CJC-1295 DAC, including its impact on deep sleep and brain wave activity.